Yellow Subretinal Lesions following Initiation of Antituberculosis Therapy in A Tubercular Choroidal Granuloma: A Sign of Paradoxical Worsening?

Ocul Immunol Inflamm. 2022 Jan 2;30(1):29-33. doi: 10.1080/09273948.2020.1780272. Epub 2020 Aug 12.

Abstract

Purpose: To describe the presentation and management of atypical subretinal lesions following initiation of antitubercular therapy for a tubercular choroidal granuloma.

Case report: An 18-year-old female was diagnosed with choroidal granuloma and shallow exudative retinal detachment in the left eye. Biopsy from a cervical lymph node was positive for tuberculosis. She was treated with antitubercular therapy (ATT) and oral steroids. After one week of therapy exudative detachment increased markedly and discrete yellowish-white subretinal lesions appeared first in the inferior periphery, then temporally and later involved the macula leading to a drop in visual acuity. A diagnosis of paradoxical worsening was considered and she was managed with a higher dose of oral corticosteroids, intravitreal methotrexate and intravitreal ranibizumab. The granuloma healed and the subretinal lesions as well as exudative detachment gradually resolved with improvement in visual acuity.

Conclusion: Subretinal yellow-white lesions may develop as a paradoxical response to ATT.

Keywords: ATT; Ocular tuberculosis; SRHM; anti tubercular therapy; choroidal granuloma; paradoxical worsening; subretinal deposits.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antitubercular Agents / adverse effects
  • Choroid*
  • Female
  • Granuloma / diagnosis
  • Granuloma / drug therapy
  • Humans
  • Ranibizumab / therapeutic use
  • Retinal Detachment* / diagnosis

Substances

  • Antitubercular Agents
  • Ranibizumab